SWOG Presents 30 Abstracts at ASCO 2023 | SWOG “Here are highlights from some of the other SWOG work to be presented at ASCO 2023…
Category: SWOG studies
From CancerNetwork: “Men with metastatic castrate resistant prostate cancer (mCRPC) with undetectable circulating tumor counts (CTCs) were 6.1-fold more likely to have complete response to…
“Amir Goldkorn, MD, of USC Norris Comprehensive Cancer Center, discusses findings from SWOG S1216, which showed that using circulating tumor cell (CTC) count at…
Watch it here: New biomarker may guide initial treatment of metastatic prostate cancer – Keck Medicine of USC (broadcastmed.net) “Prostate cancer is the most common…